Skip to main content

Pediatric Migraine Headache

High Yield Facts ⭆ 1. About fifty percent of the pediatric migraine patients continue to have migraine headache in adulthood. 2. Like adult migraine, Topiramate and Amitriptyline can be used as pharmacological prophylactic therapy in Pediatric Migraine. 3. Childhood onset migraine is a primary headache disorder. 4. Worldwide prevalence of Pediatric Migraine headache is around 7% to 8%. 5. About 30% of migraine patients, first start headache in childhood. 6. Before puberty, incidence of migraine headache is equal in male and female.

Pediatric Migraine Headache

Question

True about Pediatric Migraine Headache, except:
  1. Pediatric migraine has no risk of developing adulthood migraine.
  2. Like adult migraine, Topiramate and Amitriptyline can be used as pharmacological prophylactic therapy in pediatric migraine
  3. Pediatric migraine headache is a primary headache
  4. Worldwide prevalence of pediatric migraine headache is around 7% to 8%

References:

  • Al-Twaijri, Waleed A., and Michael I. Shevell. "Pediatric migraine equivalents: occurrence and clinical features in practice." Pediatric neurology 26.5 (2002): 365-368.
  • Maytal, Joseph, et al. "Pediatric migraine and the International Headache Society (IHS) criteria." Neurology 48.3 (1997): 602-607.
  • Lewis, Donald W., et al. "Prophylactic treatment of pediatric migraine." Headache: The Journal of Head and Face Pain 44.3 (2004): 230-237.
  • ABU‐ARAFEH, I. S. H. A. Q., et al. "Prevalence of headache and migraine in children and adolescents: A systematic review of population‐based studies." Developmental Medicine & Child Neurology 52.12 (2010): 1088-1097.

[Answer is 1. Pediatric migraine has no risk of developing adulthood migraine.]

Comments

Popular posts from this blog

Neurology: Self-Assessment

✍️ Neurology: Self-Assessment || Stroke || Part 02 || Dear Neurology Aspirants! Please! Watch the video for Self-Assessment. The assessment video contains 30 questions from the Chapter: Stroke. The video used objective questions from “The Neurology: Self-Assessment & Review" by Dr. Sunil Kumar. Hope! This will help you to manage your time in the examination hall. Best of Luck!

Kennedy Disease

Multiple Choice Questions in Neurology: True and False statements about Kennedy Syndrome: CAG repeat Gynecomastia Testicular atrophy Peripheral neuropathy Ocular muscle involvement Kennedy's Disease Inheritance X-linked recessive disorder Trinucleotide repeat: CAG gene Clinical Features Slowly progressive limb-girdle type muscle weakness Slowly progressive bulbar dysfunction Early tremor Muscle cramps Fasciculations Marked abnormal sensory nerve conduction study Degeneration of both motor and sensory neurons Lower motor neurons signs Elevated serum creatine kinase Abnormal sex hormone levels Gynecomastia Testicular atrophy Diabetes mellitus Note: Extraocular muscles are spared. References: Fischbeck, K. H. "Kennedy disease." Journal of inherited metabolic disease 20.2 (1997): 152-158. Sperfeld, Anne D., et al. "X-linked bulbospinal neuronopathy: Kennedy disease." Archives of Neurology 59.12 (2002): 1921-1926. [Answers are A. CAG repeat-True, B. Gynecomastia-True

Cerebellar Historical Facts

✍️ Introduction: When you try to kiss someone, do you know which brain part decides the speed, distance and force of lip movement during a kiss? The best kiss is nothing but a fine coordinated movement of orbicularis oris muscle. Now you are thinking, who controls the coordinated movement of the lip? It is cerebellum! ✍️ Question: Who said - “rate, range, and force of movement is governed by the cerebellum. Sir Joseph Babinski Gillman & Gillman Gordon Holmes Sir Charcot ✍️ Explanation: The cerebellum monitors the rate, range, and force of the movement. The cerebellar diseases do not cause motor weakness but it produces unilateral in-coordination. According to Gordon Holmes, cerebellum controls the “rate, range, and force” of movement. ✍️ Answer(s): 3. Gordon Holmes ✍️ Reference: Holmes, Gordon. “The Croonian Lectures on the Clinical Symptoms of Cerebellar Disease and Their Interpretation. Lecture II. 1922.” Cerebellum (London, England), vol. 6, no. 2, 2007, pp. 148–53; discussion